Immunocore Holdings IMCR
NASDAQ IMCR
$36.20 -1.37 (-3.65%)
As of: Sep 4, 2026 · 3:13 PM EDT

Immunocore Holdings (IMCR) Inventory Average (2022 - 2026)

Immunocore Holdings (IMCR) posted Inventory Average of $7.5 million for Q1 2026, up 20.96% sequentially from $6.2 million in Q4 2025, and up 22.41% YoY from $6.1 million in Q1 2025.

Analysis

Immunocore Holdings (IMCR) Inventory Average (2022 - 2026) Analysis & Trends

Immunocore Holdings has reported Inventory Average for 4 years, with the latest figure at $7.5 million in Q1 2026.

  • Quarterly Inventory Average rose 22.41% year-over-year to $7.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.5 million (up 22.41% YoY) and the FY2025 annual result came in at $6.1 million, up 22.53% from the prior year.
  • Inventory Average advanced to $7.5 million in Q1 2026 per IMCR's latest filing, from $6.2 million in the prior quarter.
  • Over five years, Inventory Average peaked at $7.5 million in Q1 2026 and troughed at $1.1 million in Q4 2022.
  • A 4-year average of $5.0 million and a median of $5.3 million in 2024 frame the typical range for Inventory Average.
  • The sharpest annual moves came in 2025 and 2026: Inventory Average surged 60.7% in 2025, then rose 22.41% in 2026.
  • Over 4 years, Inventory Average stood at $1.1 million in 2022, then surged by 371.66% to $5.0 million in 2024, then increased by 24.42% to $6.2 million in 2025, then climbed by 20.96% to $7.5 million in 2026.
  • According to Business Quant data, Inventory Average over the past three periods registered $7.5 million, $6.2 million, and $5.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 1.77 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 3.09 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn -
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 213.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn - -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 707.10 Mn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 90.57 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn - -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 137.65 Mn
10 Immunocore Holdings 1.85 Bn 965.03 Mn 114.84 Mn 8.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.02 Mn
Mar 31, 2026 7.50 Mn
Dec 31, 2025 6.20 Mn
Sep 30, 2025 5.56 Mn
Jun 30, 2025 6.13 Mn
Mar 31, 2025 6.13 Mn
Dec 31, 2024 4.98 Mn
Sep 30, 2024 3.99 Mn
Jun 30, 2024 3.81 Mn
Mar 31, 2024 4.33 Mn
Dec 31, 2022 1.06 Mn